Friday, July 10, 2026

pharma · Obese · Hyperlipemia

Suzhou Ribo Life

Suzhou Ribo Life is a pharma organization headquartered in CN. Primary therapeutic focus areas include Obese, Hyperlipemia, Non-small Cell Lung Cancer, Rheumatoid Arthritis (RA). NovaPharmaNews links 4 clinical program(s

Beijing, CN HQ
2007 Founded
32 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Beijing, CN
Founded
2007
Employees
32
Programs
4
Drugs
7
Patents
0
Clinical program

UTAA91 injection

Phase 1 · mab · Rheumatoid Arthritis (RA)

UTAA91 injection for Rheumatoid Arthritis (RA) is a Phase 1 program (mab) at Suzhou Ribo Life Science Co. with 1 ClinicalTrials.gov record(s).

Internal code PG-011-9

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Suzhou Ribo Life Science Co.
Phase
Phase 1
Modality
mab
Indication
Rheumatoid Arthritis (RA)
Status
active
Trials
1

Clinical trials